What is the recommended taper schedule for clonazepam (Klonopin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Clonazepam (Klonopin) Tapering Schedule

For patients taking clonazepam, the recommended tapering approach is to reduce the dose by 10% of the most recent dose every 2-4 weeks, with slower tapers of 10% per month or less for long-term users (≥1 year). 1

General Tapering Principles

  • Tapering should be individualized based on duration of use, with longer-term users requiring slower tapers to minimize withdrawal symptoms 2, 1
  • Patient agreement and involvement in the tapering plan significantly improves success rates 2, 1
  • For most patients, reducing by 10% of the most recent dose (not the original dose) every 2-4 weeks provides a balance between progress and tolerability 1, 3
  • Long-term users (≥1 year) may require much slower tapers of 10% per month or less 2, 1

Specific Clonazepam Tapering Protocol

  • For patients on clonazepam, research supports reducing the dose by 0.25 mg per week after reaching 1 mg daily 4
  • For higher doses, begin with reductions of 0.5 mg every 2 weeks until reaching 1 mg daily, then slow to 0.25 mg weekly reductions 4
  • Example: For a patient on 2 mg daily
    • Weeks 1-2: Reduce to 1.5 mg daily
    • Weeks 3-4: Reduce to 1 mg daily
    • Week 5: Reduce to 0.75 mg daily
    • Week 6: Reduce to 0.5 mg daily
    • Week 7: Reduce to 0.25 mg daily
    • Week 8: Discontinue 4

Monitoring and Management

  • Monitor patients at least monthly during the tapering process 2, 1
  • Watch for withdrawal symptoms including anxiety, insomnia, tremor, sweating, tachycardia, nausea, and headache 2, 4
  • If withdrawal symptoms become severe, return to the previous well-tolerated dose and slow the taper further 2, 1
  • Consider adjunctive medications for specific withdrawal symptoms:
    • α2-agonists like clonidine or tizanidine for autonomic symptoms 2, 1
    • Trazodone, gabapentin, or mirtazapine for short-term management of insomnia or anxiety 2

Special Considerations

  • Never abruptly discontinue clonazepam except in cases of confirmed diversion or serious medical toxicity 2, 1
  • Patients with seizure disorders require even slower tapers to prevent withdrawal seizures 3
  • For patients also taking opioids, consider tapering the benzodiazepine first 3
  • Incorporate non-pharmacological approaches during tapering:
    • Cognitive behavioral therapy for anxiety management 1, 3
    • Stress reduction techniques and physical activity 3

Common Pitfalls to Avoid

  • Tapering too quickly (faster than 10% reduction every 2-4 weeks) increases withdrawal risk 1
  • Setting arbitrary time limits for completing the taper often leads to failure 1
  • Failing to pause the taper when patients experience significant withdrawal symptoms 2, 1
  • Not prescribing the lowest available dose before complete discontinuation 5

Follow-up Recommendations

  • If the taper becomes difficult, consider pausing at the current dose rather than abandoning the patient or the tapering plan 2, 3
  • Educate patients about increased risk of overdose if returning to previous higher doses 2, 3
  • Continue monitoring for several months after complete discontinuation to assess for recurrence of underlying conditions versus withdrawal symptoms 2, 1

References

Guideline

Lorazepam Tapering Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diazepam Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antidepressant Tapering Is Not Routine But Could Be.

Journal of the American Board of Family Medicine : JABFM, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.